100
Views
3
CrossRef citations to date
0
Altmetric
ARTICLES

Immune Privilege Persists in Eyes with Extreme Inflammation Induced by Intravitreal LPS

&
Pages 249-259 | Received 19 Jun 2001, Accepted 04 Oct 2001, Published online: 08 Jul 2009

REFERENCES

  • Gery I, Streilein J W. Autoimmunity in the eye and its regulation. Curr Opin Immunol 1994; 6: 938–945
  • Streilein J W. Immunology and immunopathology of corneal transplantation. Chem Immunol 1999; 73: 186–206
  • Dana M R, Streilein J W. Loss and restoration of immune privilege in eyes with corneal neovascularization. Invest Ophthalmol Vis Sci 1996; 37: 2485–2494
  • Whitcup S M, Rizzo L V, Lai J C, Hayashi S, Gazzinelli R, Chan C C. IL-12 inhibits endotoxin-induced inflammation in the eye. Eur J Immunol 1996; 26: 995–999
  • Rosenbaum J T, Kilevit P, Han Y B, Park J M, Planck S R. Interleukin-6 does not mediate endotoxin-induced uveitis in mice: studies in gene deletion animals. Invest Ophthalmol Vis Sci 1998; 39: 64–69
  • Rosenbaum J T, Angell E. Paradoxical effects of IL-10 in endotoxin-induced uveitis. J. Immunol 1995; 155: 4090–4094
  • Ohta K, Wiggert B, Taylor A W, Streilein J W. Effects of experimental ocular inflammation on ocular immune privilege. Invest Ophthalmol Vis Sci 1990; 40: 2010–2018
  • Caspi R R, Roberge F G, Chan C C, Wiggert B, Chader G J, Rozenszajn L A, Lando Z, Nussenblatt R B. A new model of autoimmune disease. Experimental autoimmune uveoretinitis induced in mice with two different retinal antigens. J Immunol 1988; 140: 1490–1495
  • Yokol H, Kato K, Kezuka T, Sakai J, Usui M, Yagita H, Okumura K. Prevention of experimental autoimmune uveoretinitis by monoclonal antibody to interleukin-12. Eur J Immunol 1997; 27: 641–646
  • Zhang M, Chan C C, Vistica B, Hung V, Wiggert B, Gery I. Copolymer 1 inhibits experimental autoimmune uveoretinitis. J Neuroimmunol 2000; 103: 189–194
  • Niederkorn J Y, Shadduck J A, Streilein J W. Immunogenetic basis for immunologic privilege in the anterior chamber of the eye. Immunogenetics 1981; 13: 227–236
  • Streilein J W. Ocular immune privilege and the Faustian dilemma. The Proctor Lecture. Invest Ophthalmol Vis Sci 1996; 37: 1940–1950
  • Streilein J W, Niederkorn J Y. Induction of anterior chamber-associated immune deviation requires an intact, functional spleen. J Exp Med 1981; 153: 1058–1067
  • Williamson J SP, Streilein J W. Impaired induction of delayed hypersensitivity following anterior chamber inoculation of alloantigens. Reg Immunol 1988; 1: 14–23
  • Ohta K, Yamagami S, Taylor A W, Streilein J W. IL-6 antagonizes TGF-beta and abolishes immune privilege in eyes with endotoxin-induced uveitis. Invest Ophthamol Vis Sci 2000; 41: 2591–2599
  • Kaiser C J, Ksander B R, Streilein J W. Inhibition of lymphocyte proliferation by aqueous humor. Reg Immunol 1989; 2: 42–49
  • Ohta K, Wiggert B, Yamagami S, Taylor A W, Streilein J W. Analysis of immunomodulatory activities of aqueous humor from eyes of mice with experimental autoimmune uveitis. J Immunol 2000; 164: 1185–1192
  • Taylor A W. Ocular immunosuppressive microenvironment. Chem Immunol 1999; 73: 72–89
  • Howes E L, Wong K L, Hartiala K T, Webster R O, Rosenbaum J T. Complement and polymorphonuclear leukocytes do not determine the vascular permeability induced by intraocular LPS. Am J Pathol 1985; 118: 35–42
  • Mo J S, Matsukawa A, Ohkawara S, Yoshinaga M. Involvement of TNF alpha, IL-1 beta and IL-1 receptor antagonist in LPS-induced rabbit uveitis. Exp Eye Res 1998; 66: 547–557

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.